-

HCA Healthcare, Inc. 1st Quarter 2025 Earnings Conference Call

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:

What: HCA Healthcare, Inc. 1Q 2025 Earnings Call
When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern)
How: Live Audio over the Internet:

https://investor.hcahealthcare.com/events-and-presentations/default.aspx

Contact:

Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com

If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

HCA Healthcare

NYSE:HCA

Release Versions

Contacts

INVESTOR CONTACT:
Frank Morgan
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

More News From HCA Healthcare

HCA Healthcare Reports First Quarter 2025 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same f...

Two Large Clinical Trials Find a Highly Effective Method to Select Appropriate Antibiotics for Patients Hospitalized With Abdominal or Skin and Soft Tissue Infection

NASHVILLE, Tenn. & ORANGE, Calif. & BOSTON--(BUSINESS WIRE)--Two large multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine, Harvard Pilgrim Health Care Institute, and HCA Healthcare have found a highly effective method to improve antibiotic selection for patients who are hospitalized with abdominal or skin and soft tissue infection to reduce their risk of antibiotic resistance. Results were published in JAMA Surgery and JAMA Internal M...

HCA Healthcare Named One of the World’s Most Admired Companies by Fortune

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has been named on Fortune’s 2025 World’s Most Admired Companies list. HCA Healthcare is ranked first overall in its industry. “It is an honor to be named a World’s Most Admired Company by Fortune again this year,” said Sam Hazen, CEO of HCA Healthcare. “Recognition on this list underscores our unwavering dedication to our colleagues and patients as we con...
Back to Newsroom